Lobarstin Enhances Chemosensitivity in Human Glioblastoma T98G Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Il-Chan | - |
dc.contributor.author | Kim, Sojin | - |
dc.contributor.author | Jo, Sungsin | - |
dc.contributor.author | Lee, Hongki | - |
dc.contributor.author | Kim, Tae Ue | - |
dc.contributor.author | Yim, Joung Han | - |
dc.contributor.author | Chung, Heekyoung | - |
dc.date.accessioned | 2017-08-03T12:52:33Z | - |
dc.date.available | 2017-08-03T12:52:33Z | - |
dc.date.issued | 2013 | - |
dc.description.abstract | Lobarstin is a metabolite occurring from the Antarctic lichen Stereocaulon alpnum. Human glioblastoma is highly resistant to chemotherapy with temozolomide. Lobarstin was examined for its effect on glioblastoma. Materials and Methods: Temozolomideresistant T98G cells were subjected to toxicity test with temozolomide and/or lobarstin. DNA damage and recovery was assessed by the alkaline comet assay and expression of DNA repair genes was examined by RT-PCR and western blot analysis. Results: Lobarstin alone at 40 μM was toxic against T98G, but had no effect in primary human fibroblasts. Cotreatment of lobarstin with temozolomide yielded enhanced toxicity. Temozolomide-alone or with lobarstin co-treatment gave similar extent of DNA damage. However, the recovery was reduced in co-treated cells. Expression of DNA repair genes, O6-methylguanine-DNA methyltransferase, poly(ADPribose) polymerase 1 and ligase 3 were reduced in lobarstintreated cells. Conclusion: Enhanced sensitivity to temozolomide by lobarstin co-treatment may be attributed to reduced DNA repair. | - |
dc.format | application/pdf | - |
dc.language | English | - |
dc.title | Lobarstin Enhances Chemosensitivity in Human Glioblastoma T98G Cells | - |
dc.title.alternative | 인간 Glioblastoma T98G 세포에서 극지생물 유래 Lobarstin에 의한 항암효과 민감성 증대에 관한 연구 | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | Kim, Il-Chan, et al. 2013. "Lobarstin Enhances Chemosensitivity in Human Glioblastoma T98G Cells". <em>ANTICANCER RESEARCH</em>, 33(12): 5445-5452-5451. | - |
dc.citation.title | ANTICANCER RESEARCH | - |
dc.citation.volume | 33 | - |
dc.citation.number | 12 | - |
dc.citation.page | 5445-5452 | - |
dc.identifier.doi | 0250-7005/2013 $2.00+.40 | - |
dc.citation.startPage | 5445 | - |
dc.citation.endPage | 5451 | - |
dc.description.articleClassification | SCI | - |
dc.description.jcrRate | JCR 2011:74.11 | - |
dc.subject.keyword | Lobarstin | - |
dc.subject.keyword | Glioblastoma | - |
dc.subject.keyword | Temozolomide | - |
dc.subject.keyword | Chemosensitivity | - |
dc.subject.keyword | DNA repair | - |
dc.identifier.localId | 2013-0454 | - |
dc.identifier.scopusid | 2-s2.0-84891408808 | - |
dc.identifier.wosid | 000328801900028 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.